ReviewFrontiers in oncology2026
Targeting β-catenin: PROTACs and precision degraders for Wnt-driven cancers.
Jonathan Trapani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewFrontiers in oncology2026
Jonathan Trapani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.